Xanthohumol from hop (Humulus lupulus) has demonstrated antiproliferative and cytotoxic effects in human cancer cell lines. It has been shown to inhibit DGAT (diacylglycerol acetyltransferase) and human CYP (cytochrome P450 enzymes). It has also been shown to inhibit the expression of HIF-1α and VEGF under hypoxic conditions. Xanthohumol from hop (Humulus lupulus) is an inhibitor of DNA Polymerase, VCP and PKB Kinase.
1. Miranda, C.L. et. al., Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem. Toxicol. 37, 271-285, (1999) 2. Tabata, N. et. al., Xanthohumols, diacylglycerol acyltransferase inhibitors, from Humulus lupulus. Phytochemistry 46, 683-687, (1997) 3. Henderson, M.C., et. al., In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica 30, 235-251, (2000) 4. Gerhauser, C. et. al., Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 1, 959-969, (2002)
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.